NCT05878834Completed
Efficacy and Safety of Beta-glucan Supplement in Chronic Obstructive Pulmonary Disease Patients
Source: ClinicalTrials.gov · Last updated 5 Oct 2026
Brief summary (registry, in English)
The objectives of this study are to evaluate Efficacy and safety of beta-glucan supplement in chronic obstructive pulmonary disease patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 42 (actual)
- First submitted
- 18 May 2023
- Start date
- 25 May 2023
- Primary completion date
- 30 Nov 2025
- Lead sponsor
- Chulalongkorn University
- Diseases
- COPD
- NCT number
- NCT05878834
What you commit to
- Study type: Interventional
- Participants enrolled: 42
- From 25 May 2023 to the primary completion date, 30 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Lung surgery history
Other illness
- Respiratory infection in 4 weeks
- Lung cancer, abnormal pulmonary lesions on chest radiography
- Liver disease or kidney disease
- Allergic to beta-glucan, broccoli, or quercetin
Other
- Take lung supplement in 2 weeks
- Take warfarin, clopidogrel, aspirin, or digoxin
- Cannot use Spirometry
- Pregnancy and lactation
Who the study is looking for
- Age more than 18 years
- Chronic Obstructive Pulmonary Disease with Forced expiratory volume in 1 second/Forced vital capacity after receiving bronchodilator medicine less than or equal to 70%
- No exacerbation and uncontrolled disease
- Willing to participate in this study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Police General Hospital Coordinator of this site? Confirm its status | Bangkok | Thailand | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.